alpha-aminopyridine has been researched along with Acute Promyelocytic Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fu, X; Li, SJ; Liu, Y; Peng, J; Zhao, XL | 1 |
Bashash, D; Delshad, M; Ghaffari, SH; Momeny, M; Safa, M; Safaroghli-Azar, A | 1 |
Bashash, D; Delshad, M; Momeny, M; Pourbagheri-Sigaroodi, A; Riyahi, N; Safaroghli-Azar, A | 1 |
3 other study(ies) available for alpha-aminopyridine and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Chidamide acts on the histone deacetylase-mediated miR-34a/Bcl-2 axis to regulate NB4 cell line proliferation and apoptosis.
Topics: Aminopyridines; Apoptosis; Base Sequence; Benzamides; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Leukemic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leukemia, Promyelocytic, Acute; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; Up-Regulation | 2020 |
Novel pan PI3K inhibitor-induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120.
Topics: Aminopyridines; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA; Enzyme Activation; Enzyme Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Morpholines; NF-kappa B; Phosphoinositide-3 Kinase Inhibitors; S Phase; Signal Transduction; Telomerase | 2017 |
Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120.
Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Caspase 3; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Intracellular Space; Leukemia, Promyelocytic, Acute; Morpholines; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species; Signal Transduction | 2018 |